David Gerring
Corporate Officer/Principal bij ARECOR THERAPEUTICS PLC
Vermogen: 264 284 $ op 30-04-2024
Actieve functies van David Gerring
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ARECOR THERAPEUTICS PLC | Corporate Officer/Principal | - | - |
Arecor Ltd.
 Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | - |
Loopbaan van David Gerring
Statistieken
Internationaal
| Verenigd Koninkrijk | 3 |
Operationeel
| Corporate Officer/Principal | 2 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ARECOR THERAPEUTICS PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- David Gerring
- Ervaring
